Financials
Financial year 2025
Worth noting
- A loss two years in a row.
- The team shrank two years in a row.
Gross margin
€ -626,490
▲ 9% vs 2024
Profit
Caution€ -2.3 million
▼ 3% vs 2024
Debts
Low€ 2 million
▼ 5% vs 2024
DENDROGENIX from Liège, company number BE0700613677, closed financial year 2025 with a result of € -2.3 million after tax. For that financial year DENDROGENIX recorded a gross margin of € -626,490 and equity of € 3.3 million. Compared with financial year 2024, the result moved from € -2.2 million to € -2.3 million. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 2, 2026.
What happened at DENDROGENIX?
What happened at DENDROGENIX in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- NOSHAQ SPIN-OFFS SA stepped down as director. NBB
- Stéphane SILVENTE stepped down as director. NBB
- Philippe LEFEBVRE stepped down as director. NBB
- Emile LORIA stepped down as director. NBB
- Jean COMBALBERT stepped down as director. NBB
- Ingeborg HOCHMAIR stepped down as director. NBB
- Jean-Michel FOIDART stepped down as director. NBB
- SPARAXIS stepped down as director. NBB
In short
From € 1.6 million loss in 2021 to € 2.3 million loss in 2025.
A new publication or filing at DENDROGENIX? We notify you, reason included.
Follow DENDROGENIXNeed more data?
History
Every financial year, as far back as the National Bank goes.
Buffer
How long does the company survive without income?
Credit limit
Indicative credit limit, computed from the real figures.
Alerts
News about who you follow, reason included.
Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.
Management
Directors
According to the 2025 annual accounts
since 2022 · until 2028
Philippe LEFEBVRE
Director
Also active at: Fonds Léon Frédéricq pour la Promotion des Recherches médicales, fondamentales et cliniques, auprès du Centre HospitalierUniversitaire de Liège, Bridge2Health, ORL.Dr.P .LEFEBVRE
since 2024 · until 2030
Director · represented by FRANÇOISE JOSÉE THIELEN CAROLINE
Also active at: C.P. Bourg, A.M.B., Jean Goldschmidt International +228 more
since 2022 · until 2028
Director · represented by PATRICK ALAIN FRANCIS GHISLAIN STRAGIER
Also active at: SCIENCE PARK SERVICES, ARAPONICS
since 2026 · until 2032
Stéphane SILVENTE
Director
since 2026 · until 2032
Jean COMBALBERT
Director
since 2023 · until 2029
Ingeborg HOCHMAIR
Director
since 2023 · until 2029
Emile LORIA
Director
since 2024 · until 2030
Establishments
Establishment units
Physical locations of this company
Avenue de l'Hôpital 11
4000 Liège
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 5 companies are registered at this address.
Details
- Company number
- 0700.613.677
- VAT number
- BE 0700.613.677
- Registered office
- Avenue de l'Hôpital 11, 4000 Liège
- Names & denominations
- DENDROGENIX
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 2 August 2018
- Peppol
- Active · Active since 31 Oct 2025
- Activities · NACE
Speur- en ontwikkelingswerk op biotechnologisch gebied
Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied
Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied